Hepatic Dysfunction Secondary to Severe Cardiogenic Shock Evolving to Heart Transplantation
Keywords:
Heart Transplantation, Myocarditis, Shock, Cardiogenic, Multiple Organ Failure, Liver Failure, AcuteAbstract
Rarely, respiratory viruses and their representatives could cause severe acute myocarditis, with progression to cardiogenic shock in young adults. This is a descriptive case report detailing the procedures adopted at the Hospital de Clínicas da Unicamp, during the period of professional training for the intensive care medical residency, seeking to anchor the practical procedures in the available literature on the subject, however scarce it may be. The objective of this report is to expose its occurrence, given its low incidence, as a form of academic contribution and as a provocateur of opinions based on evidence in the management of a cardiogenic shock that culminated in a successful heart transplant.
Downloads
References
1. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol. 2014 jan; 67(1): 46-51. https://doi.org/10.1016/j.jclinepi.2013.08.003
2. Dias FS, Rezende E, Mendes CL, Réa-Neto Á, David CM, Schettino G, et al. Parte II: monitorização hemodinâmica básica e cateter de artéria pulmonar. Rev Bras Ter Intensiva. 2006 mar; 18(1): 63-77. https://doi.org/10.1590/S0103-507X2006000100012
3. Shabana A, Dholoo F, Banerjee P. Inotropic agents and vasopressors in the treatment of cardiogenic shock. Curr Heart Fail Rep. 2020 oct; 1: 438-448. https://doi.org/10.1007/s11897-020-00493-9
4. Kasper P, Tacke F, Steffen H-M, Michels G. Hepatische dysfunktion bei patienten mit kardiogenem schock. Med Klin - Intensivmed Notfallmedizin. 2019 sep; 114: 665-676. https://doi.org/10.1007/s00063-019-00618-6
5. Waseem N, Chen PH. Hypoxic hepatitis: a review and clinical update. J Clin Transl Hepatol. 2016; 4(3): 263-268. https://doi.org/10.14218/JCTH.2016.00022
6. Hernandez GA, Lemor A, Blumer V, Rueda CA, Zalawadiya S, Stevenson LW, Lindenfeld J. Trends in utilization and outcomes of pulmonary artery catheterization in heart failure with and without cardiogenic shock. J Card Fail. 2019 may; 25(5): 364-371. https://doi.org/10.1016/j.cardfail.2019.03.004
7. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012 oct; 367(14): 1287-1296. https://doi.org/10.1056/NEJMoa1208410.
8. van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017 oct; 136(16): e232-e268. https://doi.org/10.1161/CIR.0000000000000525
9. Bacal F, Marcondes-Braga FG, Rohde LEP, Xavier JL Júnior, Brito FS, Moura LAZ, et al. 3ª Diretriz Brasileira de Transplante Cardíaco. Arq Bras Cardiol. 2018 ago; 111(2): 230-289. https://doi.org/10.5935/abc.20180153
10. Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021 mar; 18: 169-193. https://doi.org/10.1038/s41569-020-00435-x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Samira Dias dos Passos, Thais Maria Pivezan Neves, Seok Woo Shin, Felicio Chueiri Neto
This work is licensed under a Creative Commons Attribution 4.0 International License.
